New heart valve offers hope for High-Risk patients with severe aortic stenosis
NCT ID NCT04982588
First seen Dec 08, 2025 · Last updated Jun 11, 2026 · Updated 30 times
Summary
This study tests a new heart valve device (Medtronic CoreValve Evolut PRO) in 52 Chinese patients with severe aortic stenosis who are too high-risk for open-heart surgery. The goal is to see if the device is safe and effective at replacing the damaged valve without major surgery. Patients will be monitored for survival and valve function after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE SYMPTOMATIC AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, 100000, China
-
Chinese PLA General Hospital, Chinese PLA Medical School
Beijing, Beijing Municipality, 100000, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610000, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.